Lena Allweiss

7.2k total citations · 1 hit paper
66 papers, 2.8k citations indexed

About

Lena Allweiss is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Lena Allweiss has authored 66 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Epidemiology, 50 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Lena Allweiss's work include Hepatitis B Virus Studies (58 papers), Hepatitis C virus research (47 papers) and Liver Disease Diagnosis and Treatment (28 papers). Lena Allweiss is often cited by papers focused on Hepatitis B Virus Studies (58 papers), Hepatitis C virus research (47 papers) and Liver Disease Diagnosis and Treatment (28 papers). Lena Allweiss collaborates with scholars based in Germany, United States and France. Lena Allweiss's co-authors include Maura Dandri, Tassilo Volz, Marc Lütgehetmann, Ansgar W. Lohse, Joerg Petersen, Stephan Urban, Katja Giersch, Teresa Pollicino, Massimo Levrero and Laura Belloni and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.

In The Last Decade

Lena Allweiss

62 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome

2012 444 citations Lena Allweiss, Tassilo Volz et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lena Allweiss Germany	25	2.5k	2.1k	387	369	287	66	2.8k
Liran Fu China	7	1.5k 0.6×	1.1k 0.5×	365 0.9×	336 0.9×	186 0.6×	12	1.9k
Julie Lucifora France	27	1.8k 0.7×	1.4k 0.6×	434 1.1×	388 1.1×	491 1.7×	63	2.3k
Shuping Tong United States	30	2.8k 1.1×	2.5k 1.2×	337 0.9×	453 1.2×	169 0.6×	90	3.1k
Bernadette Guerra United States	21	1.4k 0.6×	1.5k 0.7×	367 0.9×	295 0.8×	422 1.5×	29	2.2k
Stephan Menne United States	27	1.7k 0.7×	1.4k 0.6×	266 0.7×	411 1.1×	435 1.5×	85	2.1k
Jisu Li United States	25	1.8k 0.7×	1.6k 0.8×	268 0.7×	290 0.8×	120 0.4×	59	2.1k
Michael J. McGarvey United Kingdom	18	1.6k 0.6×	1.4k 0.7×	325 0.8×	250 0.7×	135 0.5×	33	1.9k
Agata Budkowska France	25	1.3k 0.5×	1.3k 0.6×	435 1.1×	200 0.5×	336 1.2×	60	2.0k
Jeffry Saputelli United States	16	1.7k 0.7×	1.3k 0.6×	216 0.6×	479 1.3×	106 0.4×	17	1.8k
Mei Chao Taiwan	18	1.3k 0.5×	1.1k 0.5×	385 1.0×	463 1.3×	114 0.4×	40	1.7k

Countries citing papers authored by Lena Allweiss

Since Specialization

Citations

This map shows the geographic impact of Lena Allweiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena Allweiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena Allweiss more than expected).

Fields of papers citing papers by Lena Allweiss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lena Allweiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena Allweiss. The network helps show where Lena Allweiss may publish in the future.

Co-authorship network of co-authors of Lena Allweiss

This figure shows the co-authorship network connecting the top 25 collaborators of Lena Allweiss. A scholar is included among the top collaborators of Lena Allweiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lena Allweiss. Lena Allweiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lampertico, Pietro, Pavel Bogomolov, Vladimir Chulanov, et al.. (2025). Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg‐IFNα‐2a as Treatment for Chronic Hepatitis Delta. Liver International. 45(2). e70008–e70008. 3 indexed citations

Allweiss, Lena, Vithika Suri, Jeffrey J. Wallin, et al.. (2024). Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies. Journal of Hepatology. 80(6). 882–891. 18 indexed citations

Kim, Kwang Su, Sanae Hayashi, Kazuyuki Aihara, et al.. (2024). Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markers. PLoS Computational Biology. 20(3). e1011238–e1011238. 7 indexed citations

Allweiss, Lena, et al.. (2024). Pegylated interferon-alpha treatment in vivo potently reduces all HDV markers in primary human hepatocytes undergoing cell division. Zeitschrift für Gastroenterologie. 62(1). e60–e60. 1 indexed citations

Bacher, John, Lena Allweiss, & Maura Dandri. (2024). SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential. Viruses. 16(11). 1667–1667. 5 indexed citations

Allweiss, Lena, Barbara Testoni, Yu Mei, et al.. (2023). Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure. Gut. 72(5). 972–983. 43 indexed citations

Giersch, Katja, Nora Goldmann, Tassilo Volz, et al.. (2023). Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment. JHEP Reports. 5(4). 100673–100673. 6 indexed citations

Allweiss, Lena, Vithika Suri, Jeffrey J. Wallin, et al.. (2023). Strong decline of intrahepatic HDV markers and signs of liver inflammation after 48 weeks of treatment with Bulevirtide in chronic hepatitis D patients: Combined intrahepatic results from the clinical trials MYR203 and MYR301. Zeitschrift für Gastroenterologie. 61(1). e50–e51. 1 indexed citations

Boettler, Tobias, Upkar S. Gill, Lena Allweiss, et al.. (2022). Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection. JHEP Reports. 4(6). 100480–100480. 10 indexed citations

10.

Allweiss, Lena, Katja Giersch, Tassilo Volz, et al.. (2021). Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo. Gut. 71(2). 372–381. 60 indexed citations

11.

Allweiss, Lena, et al.. (2021). Chromatin Extraction from Frozen Chimeric Liver Tissue for Chromatin Immunoprecipitation Analysis. Journal of Visualized Experiments. 1 indexed citations

12.

Giersch, Katja, Tassilo Volz, Lena Allweiss, et al.. (2021). Strong Replication Interference Between Hepatitis Delta Viruses in Human Liver Chimeric Mice. Frontiers in Microbiology. 12. 671466–671466. 4 indexed citations

13.

Wisskirchen, Karin, Janine Kah, Antje Malo, et al.. (2019). T cell receptor grafting allows virological control of hepatitis B virus infection. Journal of Clinical Investigation. 129(7). 2932–2945. 59 indexed citations

14.

Klumpp, Klaus, Takashi Shimada, Lena Allweiss, et al.. (2017). Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection. Gastroenterology. 154(3). 652–662.e8. 78 indexed citations

15.

Bierwolf, Jeanette, Tassilo Volz, Marc Lütgehetmann, et al.. (2016). Primary Human Hepatocytes Repopulate Livers of Mice After In Vitro Culturing and Lentiviral-Mediated Gene Transfer. Tissue Engineering Part A. 22(9-10). 742–753. 11 indexed citations

16.

Allweiss, Lena & Maura Dandri. (2016). Experimental in vitro and in vivo models for the study of human hepatitis B virus infection. Journal of Hepatology. 64(1). S17–S31. 95 indexed citations

17.

Giersch, Katja, Lena Allweiss, Tassilo Volz, et al.. (2015). Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. Journal of Hepatology. 63(2). 346–353. 97 indexed citations

18.

Bogomolov, Pavel, Н. В. Воронкова, Lena Allweiss, et al.. (2014). a proof-of-concept Phase 2a clinical trial with Hbv/hdv entry inhibitor Myrcludex B : lb-20. Hepatology. 60(6). 24 indexed citations

19.

Volz, Tassilo, Lena Allweiss, Michael Warlich, et al.. (2012). The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. Journal of Hepatology. 58(5). 861–867. 247 indexed citations

20.

Allweiss, Lena, Hans‐Peter Elsässer, Nynke Gillemans, et al.. (2010). Specificity Protein 2 (Sp2) Is Essential for Mouse Development and Autonomous Proliferation of Mouse Embryonic Fibroblasts. PLoS ONE. 5(3). e9587–e9587. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact